Nektar Therapeutics (NKTR) Gross Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Nektar Therapeutics (NKTR) Gross Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1,034.00 |
| 10 | Nektar Therapeutics | 2.45 Bn | 1.77 Bn | 3.04 Mn | 2,235.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,235.00 |
| Mar 31, 2026 | 9,410.00 |
| Dec 31, 2025 | -190.00 |
| Sep 30, 2025 | -4,169.00 |
| Jun 30, 2025 | -4,460.00 |
| Mar 31, 2025 | -11,323.00 |
| Dec 31, 2024 | 1,473.00 |
| Sep 30, 2024 | 584.00 |
| Jun 30, 2024 | -1,367.00 |
| Mar 31, 2024 | -1,909.00 |
| Dec 31, 2023 | -1,592.00 |
| Sep 30, 2023 | -3,044.00 |
| Jun 30, 2023 | -1,042.00 |
| Mar 31, 2023 | -1,128.00 |
| Dec 31, 2022 | -366.00 |
| Sep 30, 2022 | 27.00 |
| Jun 30, 2022 | 337.00 |
| Mar 31, 2022 | 293.00 |
| Dec 31, 2021 | -622.00 |
| Sep 30, 2021 | -277.00 |